Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Clin Infect Dis. 2023 Oct 13;77(8):1194-1200. doi: 10.1093/cid/ciad364.
Kidney failure is an established risk factor for tuberculosis (TB), but little is known about TB risk in people with chronic kidney disease (CKD) who have not initiated kidney replacement therapy (CKD without kidney failure). Our primary objective was to estimate the pooled relative risk of TB disease in people with CKD stages 3-5 without kidney failure compared with people without CKD. Our secondary objectives were to estimate the pooled relative risk of TB disease for all stages of CKD without kidney failure (stages 1-5) and by each CKD stage.
This review was prospectively registered (PROSPERO CRD42022342499). We systematically searched MEDLINE, Embase, and Cochrane databases for studies published between 1970 and 2022. We included original observational research estimating TB risk among people with CKD without kidney failure. Random-effects meta-analysis was performed to obtain the pooled relative risk.
Of the 6915 unique articles identified, data from 5 studies were included. The estimated pooled risk of TB was 57% higher in people with CKD stages 3-5 than in people without CKD (adjusted hazard ratio: 1.57; 95% CI: 1.22-2.03; I2 = 88%). When stratified by CKD stage, the pooled rate of TB was highest in stages 4-5 (incidence rate ratio: 3.63; 95% CI: 2.25-5.86; I2 = 89%).
People with CKD without kidney failure have an increased relative risk of TB. Further research and modeling are required to understand the risks, benefits, and CKD cutoffs for screening people for TB with CKD prior to kidney replacement therapy.
肾衰竭是结核病(TB)的既定危险因素,但人们对尚未开始肾脏替代治疗的慢性肾脏病(CKD)患者(无肾衰竭的 CKD)的 TB 风险知之甚少。我们的主要目标是估计无肾衰竭的 CKD 3-5 期患者与无 CKD 患者相比,TB 病的合并相对风险。我们的次要目标是估计无肾衰竭的所有 CKD 分期(1-5 期)和每个 CKD 分期的 TB 病的合并相对风险。
本综述前瞻性注册(PROSPERO CRD42022342499)。我们系统地检索了 1970 年至 2022 年发表的 MEDLINE、Embase 和 Cochrane 数据库中的研究。我们纳入了估计无肾衰竭的 CKD 患者中 TB 风险的原始观察性研究。采用随机效应荟萃分析获得合并相对风险。
在 6915 篇独特的文章中,有 5 项研究的数据被纳入。与无 CKD 患者相比,CKD 3-5 期患者的 TB 风险估计高出 57%(调整后的危险比:1.57;95%CI:1.22-2.03;I2=88%)。按 CKD 分期分层,TB 的合并发生率在 4-5 期最高(发病率比:3.63;95%CI:2.25-5.86;I2=89%)。
无肾衰竭的 CKD 患者发生 TB 的相对风险增加。需要进一步研究和建模,以了解在进行肾脏替代治疗之前,用 CKD 筛查 TB 的风险、获益和 CKD 切点。